baber/WOPTO huggingface dataset:
Patent AU-1807392-A (AU)
Title: Amidino compounds, their manufacture and methods of treatment
IPC: C07C257/18
Filed: 1992-06-05
Abstract: The invention relates to the compounds of the formula <CHEM>  and pharmaceutically acceptable salts thereof, in which: R1 is amino which is mono- or disubstituted by a substituent selected from an aliphatic hydrocarbon radical, an araliphatic hydrocarbon radical, an aromatic radical, and a cycloaliphatic hydrocarbon radical or is amino which is disubstituted by a divalent aliphatic hydrocarbon radical; R2 is hydrogen, halogen, trifluoromethyl, an aliphatic hydrocarbon radical, or is hydroxy which is etherified by an aliphatic alcohol, araliphatic alcohol, or aromatic alcohol or which is esterified by an aliphatic or araliphatic carboxylic acid; R3 is hydrogen or an acyl radical which is derived from an organic carbonic acid, un organic carboxylic acid, a sulfonic acid, or a carbamic acid; X1 and X3, independently of one another, are oxygen (-O-) or sulphur (-S-); and X2 is a divalent aliphatic hydrocarbon radical which may be interrupted by an aromatic radical; wherein the phenyl rings of formula I may be, independently of one another, further substituted by one or more substituents selected from halogen, trifluoromethyl, un aliphatic hydrocarbon radical, hydroxy, and hydroxy which is etherified by an aliphatic alcohol or which is esterified by an aliphatic or araliphatic carboxylic acid; wherein aryl in the above definitions may be, independently of one another, further substituted by one or more substituents selected from halogen, trifluoromethyl, un aliphatic hydrocarbon radical, hydroxy, and hydroxy which is etherified by an aliphatic alcohol or which is esterified by an aliphatic or araliphatic carboxylic acid; wherein a cycloaliphatic hydrocarbon radical may be substituted by an aliphatic radical. The compounds are useful as selective LTB-4 receptor antagonists in the treatment of conditions or syndromes in mammals which are responsive to LTB-4 receptor antagonism.
Patent AU-1834399-A (AU)
Title: Shooting pot actuator for an injection molding machine
Inventor: SCHAD ROBERT
IPC: B29C45/76
Filed: 1999-02-19
Abstract: A shooting pot actuator for an injection molding machine having two plates carrying pusher rods for pushing against injection plungers within the shooting pots. The plates are mounted outside the mold and the clamp unit, and the pushers extend through bores in the stationary platen of the clamp unit to reach the injection plungers. The actuator reduces the cost and complication of mold design and production, and permits simplified adjustment of the injection plunger stroke. <IMAGE>
Patent AU-1885388-A (AU)
Title: 2-(heterocyclylalkyl)imidazopyridines
Inventor: JANSSENS FRANS EDUARD
IPC: C07D471/04
Filed: 1988-07-08
Abstract: Antiallergic 2-(heterocyclylalkyl)imidazopyridines of formula <CHEM>  wherein -A<1>=A<2>-A<3>=A<4>- is -N=CH-CH=CH-, -CH=N-CH=CH-, -CH=CH-N=CH-, -CH=CH-CH=N-, -N=CH-N=CH- or -CH=N-CH=N-; R<1> is hydrogen, C1-10alkyl, C3-6cycloalkyl, Ar<1>, C1-6alkyl or a radical of formula -Alk-G-R<2>;  R is hydrogen or C1-6alkyl;  m is 1 to 4;  n is 1 or 2; L is hydrogen, C1-6alkylcarbonyl, C1-6alkylsulfonyl, C1-6alkyloxycarbonyl, Ar<2>-C1-6alkyloxycarbonyl, Ar<2>-carbonyl, Ar<2>-sulfonyl, C3-6cycloalkyl, C2-6alkenyl optionally substituted with Ar<2>, C1-12alkyl, a radical of formula -Alk-R<4>, -Alk-Y-R<5>, Alk-Z<1>-C(X)-Z<2>-R<6> or -CH2-CHOH-CH2-O-R<7>; the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof, novel compounds of formula (I); pharmaceutical compositions containing such compounds as an active ingredient and methods of preparing said compounds and pharmaceutical compositions.
Patent AU-2118383-A (AU)
Title: 2,3-dihydro-3-oxo-1h-isoindole derivatives
Inventor: DOLAK TERENCE M
IPC: C07D401/04
Filed: 1983-11-11
Abstract: Novel phthalimide intermediates are reduced to 5-sulfamoyl-6-halo-3-oxoisoindole compounds bearing a substituted 1-phenylalkyl-4-piperidinyl moiety as the isoindole N-substitutent. Preferred compounds such as 6-chloro-2,3-dihydro-3-oxo-2-[1-(phenylmethyl)-4-piperidinyl]-1H-isoindole-5-sulfonamide exhibit diuretic and antihypertensive properties.
Patent AU-2162899-A (AU)
Title: Method for producing oxalkylated amines or alcohols
Inventor: MOHR JURGEN
IPC: C07C29/128
Filed: 1998-12-17
Abstract: In a process for preparing alkoxylated amines or alcohols in which a reaction mixture comprising an amine or an alcohol or a mixture of two or more amines and/or alcohols and an alkylene oxide, or a mixture of two or more different alkylene oxides, is reacted in one or more successive reaction steps, at least one of the reaction steps is carried out in the presence of a basic catalyst and, in at least one of the reaction steps, formic acid or a salt of formic acid or a mixture of two or more thereof is present in the reaction mixture or the reaction mixture is admixed with formic acid or a salt of formic acid, or a mixture of two or more thereof, after the alkoxylation is complete. The alkoxylates prepared by the process of the present invention have a light color and a low odor.
Patent AU-2176695-A (AU)
Title: Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds
Inventor: KREMER KENNETH ALFRED MARTIN
IPC: A01N43/90
Filed: 1995-06-20
Abstract: The present invention provides a method for the purification of a 23-E isomer of a 23-imino derivative of a LL-F28249 compound having the structural formula I <CHEM>
Patent AU-2209300-A (AU)
Title: Method of stimulating growth in aquatic animals using growth hormones
Inventor: SONNENSCHEIN LEONARD
IPC: A61K38/27
Filed: 1999-12-22
Abstract: A method of administering growth hormone includes (a) osmotically shocking aquatic animals for about 60 seconds with a hyperosmotic salt solution; and (b) placing the shocked aquatic animals in a tank containing a solution of about 300 mg/l of growth hormone (preferably bST). The treatment solution is preferably at least slightly saline. The aquatic animals are immersed in the treatment solution for between about 30 minutes and about two hours. The growth hormone solution is supersaturated with oxygen to place the aquatic animals in a state of suspended animation. Depending on the aquatic species treated, the osmotic salt solution and the treatment solution may be refrigerated. The aquatic animals are preferably treated when less than 24 hours old.
Patent AU-2242401-A (AU)
Title: A heat exchanger arrangement and method for control of a fluid through a heat exchanger arrangement
Inventor: HELIN PEROLA MAGNUS
IPC: F28F27/02
Filed: 2000-12-07
Abstract: A plate heat exchanger (6) comprising plates (8) with port holes forming port channels (15, 16), where some passages are part of a set of tap-water passages (22) communicating with two of said port channels. A disc (12), with an opening (25), divides one (16) of the tap-water port channels into a first and a second part, such that the tap-water passages (22) are divided into at least two, serially connected, groups. An elongated temperature sensor (26) extends through the disc (12), substantially closing the opening (25). In this way, the temperature sensor may sense two different tap-water temperatures, i.e. the temperatures in the respective parts of the divided port channel, and actuate a valve, controlling the flow of a primary fluid, to an extent representative of the temperatures in both port channels.
Patent AU-2296595-A (AU)
Title: Continuous positive airway pressure system
Inventor: KOLOBOW THEODOR
IPC: B29C70/36
Filed: 1995-04-21
Abstract: A passive continuous positive airway intratracheal pulmonary ventilation system which includes an inspiration limb and an expiration limb which are pressure balanced by inflatable bags. An intratracheal pulmonary ventilation system is provided which includes a catheter having a tip which is positioned through a low resistance endotracheal tube at or near a patient's carina. A constant source of an oxygen-containing gas flows through the catheter. The catheter has a tip which deflects and reverses the flow direction of the oxygen-containing gas.
Patent AU-2453202-A (AU)
Title: Method for setting up a dialysis treatment in a dialysis machine
Inventor: VASTA ALESSANDRO
IPC: A61M1/14
Filed: 2001-07-19
Abstract: A method of setting up a dialysis treatment in a dialysis machine ( 1 ) provided with a device ( 6 ) for setting up the dialysis treatment, possessing a microprocessor ( 11 ), a data input ( 12, 13 ) and a screen ( 13 ), comprises the steps of: supplying a group of functions (U(t, P); C(t, P)) of a quantity (U; C) that is characteristic of the dialysis treatment as a function of time (t) and of a parameter (P) correlated with intermediate values (U<SUB>1</SUB>, C<SUB>1</SUB>) of each function (U(t; P); C(t; P)) of the group; selecting a subset of the group of functions (U(t, P); C(t; P)) imposing boundary conditions (U<SUB>0</SUB>, TWL, DT; C<SUB>0</SUB>, C<SUB>f</SUB>, DT; C<SUB>0</SUB>, CS, DT) that are characteristic of a particular therapy; assigning values to the parameter (P) and displaying the curves corresponding to the functions (U(t, P); C(t, P)) of the subset and to the respective values assigned to parameter (P); and selecting one of the functions ((U(t, P); C(t, P)) of the subset on the basis of the images of the curves.
Patent AU-2460092-A (AU)
Title: Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents
IPC: A61K31/513
Filed: 1992-08-10
Abstract: The novel cyclic ureas of the present invention are useful as antiarrhythmic and antifibrillatory agents and have general structure (I) <CHEM> wherein (a) X is a saturated or unsaturated, 5-, 6-, or 7-membered heterocycle or carbocycle; (b) R is selected from the group consisting of covalent bond, nil, heteroatom, carbonyl, heterocyclic ring, carbocyclic ring, alkyl, alkenyl, alkoxy, alkylamino, arylalkyl, aryloxy, acyl, acyloxy, and acylamino; (c) Y is a substituted or unsubstituted, saturated or unsaturated, 5-, 6-, or 7-membered heterocyclic ring or carbocyclic ring, or is nil; and wherein when R is nil, X and Y are fused ring systems; and when R is a covalent bond, X and Y are ring systems linked through a covalent bond; and when Y is nil, R is a covalent bond and X is bound to L through R; (d) R1, R2 and R3 are independently selected from the group consisting of nil, Cl, F, Br, NH2, CF3, OH, SO3H, CH3SO2NH, COOH, alkoxy, alkyl, alkoxycarbonyl, hydroxyalkyl, carboxyalkyl, aminoalkyl, acylamino, and acyloxy; (e) L is selected from the group consisting of alkylamino, alkenylamino, alkylimino, alkenylimino, and acylamino wherein the nitrogen atom thereof is bound to the nitrogen atom at the 1-position of the cyclic urea moiety; (f) R4 is selected from the group consisting of alkyl, alkenyl, alkynyl, alkylacyl, and heteroalkyl; (g) A is a substituted or unsubstituted, saturated or unsaturated, straight-chain or branched, C1-C8 heteroalkyl, or a substituted or unsubstituted, saturated or unsaturated heterocycle having 5-, 6-, or 7-members; and has one nitrogen atom, which is adjacent to R4; and (h) R5 is a substituted or unsubstituted C2 alkylene; and pharmaceutically-acceptable salts and esters thereof.
Patent AU-2677897-A (AU)
Title: Apparatus and method for stabilizing a centrifuge rotor
Inventor: HOWELL GARY WAYNE
IPC: F16F15/305
Filed: 1997-04-21
Abstract: A method to dampen vibrations of a centrifuge by restraining vertical movement of a disk rotatably attached to the centrifuge's drive shaft. Damping bearings contact with the disk to restrain movement. Means responsive to the radial displacement of the disk activate the damping bearings beyond a predetermined displacement.
Patent AU-2936584-A (AU)
Title: Fastener with hinged clamping member
Inventor: PONTING MICHAEL ANTHONY FRANCI
IPC: E03C1/33
Filed: 1984-06-14
Abstract: A fastener for securing a sink unit in a worktop has a clip (11) for attachment to a rail and a hinged clamping member (12) which is tightened up against the underside of the worktop by a screw (25). This threads through the hinge pin (13), and when undone allows the clamping member to swing back to and stay in an inoperative position where it will clear the edge of the hole of the worktop (19) as the unit (20) is lowered in. Doing up the screw causes the clamping member to swing and project a portion (21) under the worktop. The clamping member has guide fingers (23) which engage diametral slots (24) in the ends of the hinge pin.
Patent AU-2961795-A (AU)
Title: Overhead pusher lug assembly for packaging machines
Inventor: DISRUD JEFF A
IPC: B65G19/26
Filed: 1995-06-12
Abstract: An overhead pusher lug assembly for stabilizing the top portions of cartons in a carton packaging machine comprises an endless chain conveyor having an array of pusher lugs rotatably mounted thereto at spaced intervals. The lugs are rotatable between a first position wherein the lugs extend upwardly from the lower flight of the conveyor and a second position wherein the lugs extend downwardly from the lower flight of the conveyor for insertion between adjacent cartons on a carton conveyor. As the pusher lugs move onto the lower flight of the conveyor, they engage the end of an elongated bar, which rotates or flips the pusher lugs into place between underlying cartons so that the lugs do not impact and disfigure trailing cartons on the carton path.
Patent AU-2966797-A (AU)
Title: Process for regenerating a catalyst having a sulphur-containing active phase and contaminated by a mercury compound
Inventor: OLLIVIER JAMES
IPC: B01J27/30
Filed: 1997-05-13
Abstract: PCT No. PCT/FR97/00847 Sec. 371 Date Mar. 26, 1999 Sec. 102(e) Date Mar. 26, 1999 PCT Filed May 13, 1997 PCT Pub. No. WO97/44131 PCT Pub. Date Nov. 27, 1997The invention features a method for treating a supported catalyst with a sulphur compound based active phase and a mercury compound contaminated mineral support. This method consists in implementing the following steps: the said catalyst is contacted with a basic aqueous solution of at least one sulphide selected among alkaline metal sulphides, alkaline-earth metal sulphides or ammonium sulphide; then the catalyst is separated from the basic aqueous solution. At the end of this process, the treated catalyst shows the same characteristics as before its contamination by mercury.
Patent AU-3016097-A (AU)
Title: Developer cartridge and developing apparatus
Inventor: OMATA KAZUHIKO
IPC: G03G15/08
Filed: 1997-07-24
Abstract: A developer cartridge (C) detachably mountable to a developing apparatus (5) having a shutter (20) for closing and opening a developer receiving opening (5f), includes a cylindrical portion (12) for accommodating a developer, the cylindrical portion being provided with an opening (12a) extending along a length thereof; a sealing member (12c) for the opening; a first projection (14a1) for moving the shutter to an open position for the developer receiving opening in interrelation with rotation of the developer cartridge in a first direction; a second projection (14a2) for moving the shutter to a close position for the developer receiving opening in interrelation with rotation of the developer cartridge in a second direction which is opposite from the first direction.
Patent AU-3095189-A (AU)
Title: Agglomeration process
Inventor: HSU SHENG-HSIUNG
IPC: A23F5/38
Filed: 1989-03-02
Abstract: Agglomeration of particles of a pulverulent water-soluble material is achieved by conveying a layer (22) of the material on a porous surface towards which a laminar flow of heated humid air is directed. A reduced pressure is applied from beneath the porous surface for drawing the heated humid air to contact the conveyed material for a time sufficient for fusing particles of the material at micropores formed at points of contact between the surfaces of the particles.
Patent AU-3099889-A (AU)
Title: Densified carbonaceous fiber structures
Inventor: MCCULLOUGH FRANCIS P JR
IPC: D04H1/42
Filed: 1989-03-02
Abstract: A fibrous structure comprising a multiplicity of nonflammable, nonlinear, substantially irreversibly heat-set, first carbonaceous polymeric fibers, and at least one second nonflammable carbonaceous polymeric fiber, yarn or tow in an interlocking relationship with said first fibers; the fibrous structure is preferably densified and has a bulk density of from 4.8 to 32 kg/m<3>, and a process for producing the interlocked, fibrous structure useful as a thermal insulating and/or sound absorbing structure.
Patent AU-3116997-A (AU)
Title: Quantitation of rna transcripts using genomic dna as the internal amplification competitor
Inventor: GERDES JOHN C
IPC: C12Q1/6851
Filed: 1997-05-02
Abstract: A method for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript is provided. The process involves a duplex amplification reaction in which a single set of primers is used to amplify both genomic DNA and expressed mRNA from the same gene sequence. These primers are targeted for sequences flanking the splice junction/intron sequences for the mRNA/DNA respectively. By their use, any suitable nucleic acid amplification technology yields mRNA and DNA amplimers which are distinguishable by length and sequence heterogeneity. These amplimers are present in the final amplification reaction in ratios which are dependent upon the ratios of the expressed mRNA to the DNA in the sample, allowing the quantitation of mRNA in a sample which is normalized to the number of copies of genomic DNA since the genomic DNA acts as the internal quantitation standard, and in effect yields the amount of mRNA per cell. Any detection methodology which can detect amplimers of different lengths or sequences can be used for post amplification quantitation. This strategy may be employed for any gene system in which the mRNA sequence differs from the original genomic DNA sequence. The invention may be used, for example, in the determination of gene expression in both research and commercial applications.
Patent AU-3353895-A (AU)
Title: Token device
Inventor: STEFANO SILVIO DI
IPC: A44C21/00
Filed: 1995-03-29
Abstract: The invention concerns a token device which is used as a means of payment and consists of a coin holder (1) and a coin (2) mounted therein. The first time the coin (2) is removed, the coin holder (1) is damaged and thus the token device is devalued optically or as a result of being incapable of operation. The owner of the token device recognizes that it is a means of payment more easily than with conventional tokens or chips since it contains a universally usable coin. Nevertheless, it can be identified at a specific location where it can be exchanged and thus the advertising purpose is achieved.
Patent AU-3461797-A (AU)
Title: Fas ligand-like protein, its production and use
Inventor: NISHI KAZUNORI
IPC: C12N15/12
Filed: 1997-07-17
Abstract: This invention relates to a Fas ligand-like protein having an apotosis-inducing actibvity, etc. or its salt, a partial peptide of the protein or its salt; a DNA coding for the protein; a recombinant vector; a transformant; a method for producing the protein, a pharmaceutical composition comprising the protein, the partial peptide or its salt; and an antibody to the protein or the partial peptide. The protein, the partial peptide or its salt, and the DNA are useful as a prophylactic or therapeutic agent for cancer, viral infection, Helicobacter pylori infection, invasive staphylococcia, hepatitis, nephritis, bone disease, atherosclerosis or pain. The antibody can be used in assay of the protein, the partial peptide or its salt. The protein, the partial peptide or its salt is useful as a reagent for the screening for candidate medical compounds.
Patent AU-3530195-A (AU)
Title: Cleaning apparatus
Inventor: BAILEY WILLIAM
IPC: A61L2/10
Filed: 1995-09-26
Abstract: PCT No. PCT/GB95/02278 Sec. 371 Date Nov. 20, 1997 Sec. 102(e) Date Nov. 20, 1997 PCT Filed Sep. 26, 1995 PCT Pub. No. WO96/09842 PCT Pub. Date Apr. 4, 1996Sterilizing apparatus for sterilizing a container comprises an elongate light bulb (4, 18, 111) adapted to emit ultra violet light when energized by microwaves, and a shield (16, 110) substantially surrounding said bulb (4, 18, 111) and being adapted to support a container (6) so that said bulb is located within the container. The shield (16, 110) is transparent to microwaves.
Patent AU-3601397-A (AU)
Title: Truncated soluble tumor necrosis factor type-i and type-ii receptors
Inventor: FISHER ERIC F
IPC: A61K47/48
Filed: 1997-07-09
Abstract: Disclosed are novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Also disclosed are processes for obtaining the tumor necrosis binding proteins by recombinant genetic engineering techniques.
Patent AU-3677800-A (AU)
Title: Entertainment system and data communication network system
Inventor: CHATANI MASAYUKI
IPC: H04W4/06
Filed: 2000-04-13
Abstract: An object of the present invention is to construct a data communication network system having as a component an entertainment system that includes an entertainment apparatus to which a portable information communication terminal is freely detachably attached. In the data communication network system in accordance with the present invention, the entertainment system transmits an identification number assigned to the portable information communication terminal and input data or a message to a computer system acting as a server over a bi-directional communication network. The computer system transmits a command, which is responsive to the identification number and the input data or message, to a computer system having a database over a link realized with a LAN. The computer system retrieves information, which is associated with the input data or message, from the database, and transmits (broadcasts) the information together with the identification number to the portable information communication terminal through the link realized with radiocommunication over a unidirectional communication network. A networked data processing system serving as an asynchronous message exchange system or an asynchronous data summation and results distribution system can be constructed.
Patent AU-3912497-A (AU)
Title: Purification of antigen-specific t cells
Inventor: LUXEMBOURG ALAIN T
IPC: A61K39/00
Filed: 1997-08-12
Abstract: A new method to capture, purify and expand antigen-specific T lymphocytes has been developed using magnetic beads coated with recombinant MHC class I molecules. This method was optimized using homogenous populations of naive T cells purified from mice transgenic for the 2C T cell receptor (TCR). These T cells were captured on beads coated with MHC class I molecules and the relevant antigenic peptides. MHC and peptide specificity was confirmed by the usage of irrelevant MHC peptide combinations. An enrichment of 800 to 1600 fold was measured, using 2C T cells mixed with irrelevant T cells, starting from a 2C T cell frequency of 1/3000. The same approach was used to purify antigen-specific CD8<SUP>+</SUP> T cells from total CD8<SUP>+</SUP> T cells from naive mice. The recovered cells could be expanded and specifically kill target cells in vitro; they had a significant effect in vivo as well. We expect this procedure to be suitable to purify and expand in vitro tumor- and virus-specific killer T cells for use in cell therapy.